References

Akinyanju, O.O., 1989. A profile of sickle cell disease in Nigeria. Ann. N.Y. Acad. Sci., 565: 126-136.
CrossRef  |  PubMed  |  Direct Link  |  

Cordeiro, N.J.V. and O. Oniyangi, 2006. Phytomedicines (Medicines derived from plants) for sickle cell disease. The Cochrane Database of Systematic Review, The Cochrane Library.

Hankins, J. and B. Aygun, 2009. Pharmacotherapy in sickle cell disease-state of the art and future prospects. Br. J. Hematol., 145: 296-308.
CrossRef  |  PubMed  |  Direct Link  |  

Iyamu, E.W., E.A. Turner and T. Asakura, 2002. In vitro effects of NIPRISAN (Nix-0699): A naturally occurring, potent antisickling agent. Br. J. Haematol., 118: 337-343.
CrossRef  |  Direct Link  |  

Johnson, L., A. Carmona-Bayonas and L. Tick, 2008. Management of pain due to sickle cell disease. J. Pain Palliat Care Pharmacother., 22: 51-54.
PubMed  |  Direct Link  |  

Lesi, F.E.A., 1999. Sickle Cell Disorder: A Handbook for Patients, Parents, Counselors and Primary Health Care Practitioners. Macmillan, Nigeria, pp: 1-10.

Okpuzor, J., O. Adebesin, H. Ogbunugafor and I. Amadi, 2008. The potential of medicinal plants in sickle cell disease control: A review. Int. J. Biomed. Health Sci., 4: 47-55.
Direct Link  |  

Osunderu, O.A., 2009. Sustainable Production of Traditional Medicines in Africa. In: Appropriate Technologies for Environmental Protection in the Developing World, Yanful, E.K. (Ed.). Springer Science, Netherlands, pp: 43-51.

Van den Geest, S., 1997. Is there a role for traditional medicines in basic health services in Africa? A plea for a community perspective. Trop. Med. Int. Health, 2: 903-911.
CrossRef  |  Direct Link  |  

Wambebe, C.O., A.B. Elijah, B.O. Badru, H. Khamofu and J.A. Momoh et al., 2001. Efficacy of Niprisan in the prophylactic management of patients with sickle cell disease. Curr. Ther. Res., 62: 26-34.
CrossRef  |  Direct Link  |